Human, canine and murine BRCA1 genes: sequence comparison among species.

Five to ten percent of breast cancer in the western world may be attributed to the inheritance of highly penetrant mutations in the breast and ovarian cancer susceptibility gene, BRCA1. The biological function of BRCA1 and factors affecting expressivity, such as gene-environment and gene-gene interactions, may be more effectively studied in appropriate animal models. We report the cloning and sequencing of the canine and murine BRCA1 genes and contrast the sequences with human BRCA1. The amino terminal 120 residues of the gene are > 80% identical among the three species. The C-terminus is also highly conserved, containing an 80 amino acid stretch that is over 80% identical. Motifs of likely functional significance are maintained, including the amino terminal RING finger motif (amino acids 24-64) and the granin consensus sequence (1214-1223). The distribution of missense mutations and neutral polymorphisms identified in BRCA1-linked breast cancer suggests that disease associated missense mutations occur at highly conserved residues whereas polymorphisms are in regions of lower conservation. Among eighteen missense mutations with unknown consequences, seven occur in amino acids that are identical across species. Four of these seven (E1219D, A1708E, P1749R and M1775R) are also within conserved domains. Taken together, these data predict regions of the gene which may be critical for normal function.

[1]  M. Skolnick,et al.  Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. , 1996, Human molecular genetics.

[2]  J. Rommens,et al.  BRCA2 germline mutations in male breast cancer cases and breast cancer families , 1996, Nature Genetics.

[3]  J. Eyfjörd,et al.  A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes , 1996, Nature Genetics.

[4]  Kenneth Offit,et al.  Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer , 1996, Nature Genetics.

[5]  M. King,et al.  Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. , 1996, American journal of human genetics.

[6]  J. Rommens,et al.  The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds , 1996, Nature Genetics.

[7]  M. King,et al.  BRCA1 is secreted and exhibits properties of a granin , 1996, Nature Genetics.

[8]  B. Ponder,et al.  Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. UKCCCR Familial Ovarian Cancer Study Group. , 1996, American journal of human genetics.

[9]  M. King,et al.  Growth retardation and tumour inhibition by BRCA1 , 1996, Nature Genetics.

[10]  Julian Peto,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1996, Nature.

[11]  Barbara L. Smith,et al.  Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. , 1996, The New England journal of medicine.

[12]  J. D. Thompson,et al.  BRCA1 mutations in a population-based sample of young women with breast cancer. , 1996, The New England journal of medicine.

[13]  A. Bradley,et al.  Murine Brca1: sequence and significance for human missense mutations. , 1995, Human molecular genetics.

[14]  D. Clayton,et al.  Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation , 1995, Nature Genetics.

[15]  B. Weber,et al.  Mouse Brca1: localization sequence analysis and identification of evolutionarily conserved domains. , 1995, Human molecular genetics.

[16]  M. King,et al.  Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. , 1995, American journal of human genetics.

[17]  J. Gudmundsson,et al.  Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. , 1995, Cancer research.

[18]  P. Devilee,et al.  Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13. , 1995, British Journal of Cancer.

[19]  P. Leder,et al.  Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. , 1995, Genes & development.

[20]  L. Bennett,et al.  Isolation of the mouse homologue of BRCA1 and genetic mapping to mouse chromosome 11. , 1995, Genomics.

[21]  M. Goodson,et al.  Tissue-dependent expression of heat shock factor 2 isoforms with distinct transcriptional activities , 1995, Molecular and cellular biology.

[22]  M. King,et al.  Inherited breast and ovarian cancer. , 1995, Human molecular genetics.

[23]  T. Sugimura,et al.  Germline mutation of BRCA1 in Japanese breast cancer families. , 1995, Cancer research.

[24]  D. Birnbaum,et al.  Patterns of loss of heterozygosity at loci from chromosome arm 13q suggest a possible involvement of BRCA2 in sporadic breast tumors , 1995, Genes, chromosomes & cancer.

[25]  M. King,et al.  Mutation analysis of the BRCA1 gene in ovarian cancers. , 1995, Cancer research.

[26]  David L. Page,et al.  Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression , 1995, Nature Genetics.

[27]  A. Jeffreys,et al.  A somatic BRCA1 mutation in an ovarian tumour , 1995, Nature Genetics.

[28]  M. Skolnick,et al.  A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. , 1995, JAMA.

[29]  M. King,et al.  The search for BRCA1. , 1994, Cancer research.

[30]  Patrick Dowd,et al.  Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families , 1994, Nature Genetics.

[31]  J. Rommens,et al.  Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families , 1994, Nature Genetics.

[32]  S. Neuhausen,et al.  Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. , 1994, Cancer Research.

[33]  Francis S. Collins,et al.  Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer , 1994, Nature Genetics.

[34]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[35]  M. Skolnick,et al.  BRCA1 mutations in primary breast and ovarian carcinomas. , 1994, Science.

[36]  S. Seal,et al.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.

[37]  T. Jacks,et al.  Cooperative tumorigenic effects of germline mutations in Rb and p53 , 1994, Nature Genetics.

[38]  Y. Wan,et al.  Expression of activin receptor II and IIB mRNA isoforms in mouse reproductive organs and oocytes , 1994, Molecular reproduction and development.

[39]  P. Koopman,et al.  Alternative splicing of the first nucleotide binding fold of CFTR in mouse testes is associated with specific stages of spermatogenesis. , 1994, Genomics.

[40]  A. Bradley,et al.  Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. , 1994, Oncogene.

[41]  D. Easton,et al.  Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.

[42]  R. Weinberg,et al.  Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.

[43]  R. Lidereau,et al.  Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted. , 1993, Cancer research.

[44]  E. Lander,et al.  Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse , 1993, Cell.

[45]  G. Michael,et al.  Alpha 2-chimerin, an SH2-containing GTPase-activating protein for the ras-related protein p21rac derived by alternate splicing of the human n-chimerin gene, is selectively expressed in brain regions and testes , 1993, Molecular and cellular biology.

[46]  M. Carcangiu,et al.  Allelic loss in ovarian cancer , 1993, International journal of cancer.

[47]  W D Flanders,et al.  The lifetime risk of developing breast cancer. , 1993, Journal of the National Cancer Institute.

[48]  L. Hartmann,et al.  Human epithelial ovarian cancer allelotype. , 1993, Cancer research.

[49]  J. Rine,et al.  Identification and characterization of dinucleotide repeat (CA)n markers for genetic mapping in dog. , 1993, Genomics.

[50]  D. Easton,et al.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.

[51]  R. Lovering,et al.  Identification and preliminary characterization of a protein motif related to the zinc finger. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[52]  S. Henikoff,et al.  Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[53]  A. Joyner,et al.  A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung. , 1992, Genes & development.

[54]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[55]  P. S. Kim,et al.  X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. , 1991, Science.

[56]  H. Kondoh,et al.  Embryonic lethality resulting from disruption of both N-myc alleles in mouse zygotes. , 1991, The New biologist.

[57]  R. W. Davis,et al.  Lambda YES: a multifunctional cDNA expression vector for the isolation of genes by complementation of yeast and Escherichia coli mutations. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Allan Bradley,et al.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice , 1991, Cell.

[59]  N Risch,et al.  Genetic analysis of breast cancer in the cancer and steroid hormone study. , 1991, American journal of human genetics.

[60]  M. King,et al.  Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.

[61]  W. Lowry,et al.  Allele loss from chromosome 17 in ovarian cancer. , 1990, Oncogene.

[62]  B. Gusterson,et al.  Comparative study of human and rat mammary tumorigenesis. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[63]  M. Frohman,et al.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[64]  T. Doetschman,et al.  Targeted mutation of the Hprt gene in mouse embryonic stem cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[65]  M. King,et al.  Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[66]  J. Moulton,et al.  Mammary Tumors in a Colony of Beagle Dogs , 1986, Veterinary pathology.

[67]  D. Givol,et al.  Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. , 1985, The EMBO journal.

[68]  William D. Richardson,et al.  A short amino acid sequence able to specify nuclear location , 1984, Cell.

[69]  E. Macewen,et al.  Estrogen receptors in canine mammary tumors. , 1982, Cancer research.

[70]  Owen Ln A comparative study of canine and human breast cancer. , 1979 .

[71]  C. W. Mays,et al.  Mammary neoplasia in a closed beagle colony. , 1976, Cancer research.

[72]  J. Reif,et al.  Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. , 1974, Cancer research.

[73]  D. Goodman,et al.  Animal model of human disease: canine mammary neoplasia. , 1974, The American journal of pathology.

[74]  M. Klauber,et al.  Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. , 1968, Journal of the National Cancer Institute.

[75]  I. Fidler,et al.  The biological behavior of canine mammary neoplasms. , 1967, Journal of the American Veterinary Medical Association.

[76]  I. Fidler,et al.  A necropsy study of canine malignant mammary neoplasms. , 1967, Journal of the American Veterinary Medical Association.

[77]  P. Tonin,et al.  A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. , 1996, American Journal of Human Genetics.

[78]  C. Larsson,et al.  Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer families , 1996, Nature Genetics.

[79]  F. Collins,et al.  Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. , 1995, American journal of human genetics.

[80]  F. Collins,et al.  Somatic mutations in the BRCA1 gene in sporadic ovarian tumours , 1995, Nature Genetics.

[81]  J. Klijn,et al.  Rapid detection of BRCA1 mutations by the protein truncation test , 1995, Nature Genetics.

[82]  A. Baxevanis,et al.  Interactions of coiled coils in transcription factors: where is the specificity? , 1993, Current opinion in genetics & development.

[83]  P. Freemont The RING finger. A novel protein sequence motif related to the zinc finger. , 1993, Annals of the New York Academy of Sciences.

[84]  Y. Nakamura,et al.  Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. , 1993, Cancer research.

[85]  W. Huttner,et al.  The granin (chromogranin/secretogranin) family. , 1991, Trends in biochemical sciences.

[86]  C. J. Avers Process and pattern in evolution , 1989 .

[87]  L. Owen A comparative study of canine and human breast cancer. , 1979, Investigative & cell pathology.